Bristol-Myers Stock Analysis

BMY Stock  USD 72.91  0.00  0.00%   
The small slide in market price for the last few months could raise concerns from investors as the firm is trading at a share price of 72.91 on 1,855,732 in volume. The company directors and management did not add much value to Bristol-Myers Squibb investors in December. However, diversifying your holdings with Bristol-Myers Squibb or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.14. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Continue to Trending Equities.
The Bristol-Myers Squibb stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Bristol-Myers Squibb is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, Christmas Day ( substitute day ), New Year 's Monday, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Bristol-Myers Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bristol-Myers Squibb's ongoing operational relationships across important fundamental and technical indicators.

Bristol-Myers Stock Analysis Notes

About 79.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.44. Bristol-Myers Squibb last dividend was issued on the 5th of January 2023. The entity had 1000000:95 split on the 7th of August 2001. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company was founded in 1887 and is headquartered in New York, New York. Bristol-Myers Squibb operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 32200 people. For more info on Bristol-Myers Squibb please contact Giovanni Caforio at 212 546 4000 or go to

Bristol-Myers Squibb Upcoming and Recent Events

Earnings reports are used by Bristol-Myers Squibb to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bristol-Myers Squibb previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report4th of February 2022
Next Financial Report5th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End4th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Bristol-Myers Squibb SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Bristol-Myers Squibb prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Bristol-Myers Squibb investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Bristol-Myers Squibb specific information freely available to individual and institutional investors to make a timely investment decision.
16th of August 2022
Unclassified Corporate Event
9th of August 2022
Unclassified Corporate Event
27th of July 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
19th of July 2022
Unclassified Corporate Event
1st of July 2022
Unclassified Corporate Event
17th of June 2022
Unclassified Corporate Event
15th of June 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
3rd of June 2022
Unclassified Corporate Event

Bristol-Myers Squibb Thematic Classifications

In addition to having Bristol-Myers Squibb stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Drug manufacturing and delivery
Healthcare institutions that deliver medical services
Addiction driven consumer products and services

Bristol-Myers Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 155.19 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol-Myers Squibb's market, we take the total number of its shares issued and multiply it by Bristol-Myers Squibb's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Bristol-Myers Profitablity

Bristol-Myers Squibb's profitability indicators refer to fundamental financial ratios that showcase Bristol-Myers Squibb's ability to generate income relative to its revenue or operating costs. If, let's say, Bristol-Myers Squibb is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Bristol-Myers Squibb's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Bristol-Myers Squibb's profitability requires more research than a typical breakdown of Bristol-Myers Squibb's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.14 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.22 %, which entails that for every 100 dollars of revenue, it generated 0.0 of operating income.
Last ReportedProjected for 2023
Return on Investment 9.18  8.59 
Return on Average Assets 4.81  4.56 
Return on Average Equity 7.16  6.66 
Return on Invested Capital 0.13  0.14 
Return on Sales 0.16  0.16 

Management Efficiency

The entity has Return on Asset of 0.0613 % which means that on every $100 spent on asset, it made $0.0613 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.1912 %, implying that it generated $0.1912 on every 100 dollars invested. Bristol-Myers Squibb management efficiency ratios could be used to measure how well bristol-myers squibb manages its routine affairs as well as how well it operates its assets and liabilities. Return on Invested Capital is likely to rise to 0.14 in 2023, whereas Return on Investment is likely to drop 8.59 in 2023. Bristol-Myers Squibb Assets Non Current are fairly stable at the moment as compared to the past year. Bristol-Myers Squibb reported Assets Non Current of 87.46 Billion in 2022. Goodwill and Intangible Assets is likely to rise to about 78.2 B in 2023, whereas Total Assets are likely to drop slightly above 202.5 M in 2023.
Last ReportedProjected for 2023
Book Value per Share 18.62  16.87 
Enterprise Value over EBIT 18.90  19.40 
Enterprise Value over EBITDA 8.13  8.35 
Price to Book Value 3.47  4.06 
Tangible Assets Book Value per Share 23.98  22.51 
Enterprise Value195 B163.6 B
Tangible Asset Value53.2 B45.6 B
Long Term Debt Total
39.6 B
Non Current Liabilities Total
51.4 B
Forward Dividend Yield
Short Long Term Debt Total
45.6 B
Forward Dividend Rate

Technical Drivers

As of the 27th of January, Bristol-Myers Squibb shows the Risk Adjusted Performance of 0.0338, mean deviation of 0.8461, and Downside Deviation of 1.29. Bristol-Myers Squibb technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for nineteen technical drivers for Bristol-Myers Squibb, which can be compared to its rivals. Please confirm Bristol-Myers Squibb semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if Bristol-Myers Squibb is priced correctly, providing market reflects its regular price of 72.91 per share. Given that Bristol-Myers Squibb has jensen alpha of (0.019983), we suggest you to validate Bristol-Myers Squibb's prevailing market performance to make sure the company can sustain itself at a future point.

Bristol-Myers Squibb Price Movement Analysis

Execute Study
The output start index for this execution was fourty-eight with a total number of output elements of thirteen. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bristol-Myers Squibb middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bristol-Myers Squibb. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Bristol-Myers Squibb Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bristol-Myers Squibb insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bristol-Myers Squibb's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bristol-Myers Squibb insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Bristol-Myers Squibb Outstanding Bonds

Bristol-Myers Squibb issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bristol-Myers Squibb uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bristol-Myers bonds can be classified according to their maturity, which is the date when Bristol-Myers Squibb has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Bristol-Myers Squibb Predictive Daily Indicators

Bristol-Myers Squibb intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bristol-Myers Squibb stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Bristol-Myers Squibb Forecast Models

Bristol-Myers Squibb time-series forecasting models is one of many Bristol-Myers Squibb's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bristol-Myers Squibb's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Bristol-Myers Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bristol-Myers Squibb prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bristol-Myers shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Bristol-Myers Squibb. By using and applying Bristol-Myers Stock analysis, traders can create a robust methodology for identifying Bristol-Myers entry and exit points for their positions.
Last ReportedProjected for 2023
Operating Margin 8.28  7.76 
EBITDA Margin 6.11  5.77 
Gross Margin 53.94  59.99 
Profit Margin 6.45  5.97 

Current Bristol-Myers Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bristol-Myers analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bristol-Myers analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Bristol-Myers Squibb current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Bristol-Myers analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bristol-Myers stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bristol-Myers Squibb, talking to its executives and customers, or listening to Bristol-Myers conference calls.
Bristol-Myers Analyst Advice Details

Bristol-Myers Stock Analysis Indicators

Bristol-Myers Squibb stock analysis indicators help investors evaluate how Bristol-Myers Squibb stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bristol-Myers Squibb shares will generate the highest return on investment. By understating and applying Bristol-Myers Squibb stock analysis, traders can identify Bristol-Myers Squibb position entry and exit signals to maximize returns.
Begin Period Cash Flow15 B
Common Stock Shares Outstanding2.2 B
Total Stockholder Equity35.9 B
Total Cashflows From Investing Activities-538 M
Tax Provision1.1 B
Quarterly Earnings Growth Y O Y0.087
Property Plant And Equipment NetB
Retained Earnings23.8 B
Cash And Short Term Investments17.2 B
Retained Earnings Total Equity23.8 B
Cash14 B
Accounts Payable2.9 B
Net Debt31.6 B
50 Day M A75.4264
Total Current Liabilities21.9 B
Other Operating Expenses39 B
Non Current Assets Total76.1 B
Forward Price Earnings9.9701
Common Stock Total Equity292 M
Non Currrent Assets Other1.7 B
Continue to Trending Equities. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for analysis

When running Bristol-Myers Squibb price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Is Bristol-Myers Squibb's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol-Myers Squibb. If investors know Bristol-Myers will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol-Myers Squibb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
Market Capitalization
155.2 B
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol-Myers that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol-Myers Squibb's value that differs from its market value or its book value, called intrinsic value, which is Bristol-Myers Squibb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol-Myers Squibb's market value can be influenced by many factors that don't directly affect Bristol-Myers Squibb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol-Myers Squibb's value and its price as these two are different measures arrived at by different means. Investors typically determine Bristol-Myers Squibb value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol-Myers Squibb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.